Zobrazeno 1 - 10
of 67
pro vyhledávání: '"Thomas Kleemann"'
Autor:
Elif Kaya, Jochen Senges, Matthias Hochadel, Lars Eckardt, Dietrich Andresen, Hüseyin Ince, Stefan G. Spitzer, Thomas Kleemann, Sebastian S.K. Maier, Werner Jung, Christoph Stellbrink, Tienush Rassaf, Reza Wakili
Publikováno v:
ESC Heart Failure, Vol 7, Iss 3, Pp 984-995 (2020)
Abstract Aims Diabetes mellitus (DM) has a negative impact on prognosis in patients with heart failure (HF). The role impact of DM in HF patients with implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy (CRT) devices mig
Externí odkaz:
https://doaj.org/article/838d61bc77334bbaa866f4160c7a0a7d
Autor:
Ralf Zahn, Philippe M. Barth, Caroline Kilkowski, Boris Fraiture, Ann-Katrin Karcher, René Brütsch, Ralph Winkler, Thomas Kleemann, Steffen Schneider, Dorothee Sutor, Udo Weisse, Falk-Udo Sack
Publikováno v:
International Journal of Cardiology: Heart & Vasculature, Vol 33, Iss , Pp 100734- (2021)
Objective: Infective endocarditis (IE) is still a serious disease. The currently published EURO-ENDO registry showed a rate of surgery of 51.2% and a lower mortality in operated IE patients. We hypothesized differences between our data and the regist
Externí odkaz:
https://doaj.org/article/e473af802aaa4fdd917ccfbc09780f39
Autor:
Eleni Lampropoulou, Kleopatra Kouraki, Margit Strauss, Owais Mohammad, Ralf Zahn, Thomas Kleemann
Publikováno v:
Journal of Cardiovascular Electrophysiology. 34:1241-1248
Autor:
Felix Wiedmann, Hüseyin Ince, Christoph Stellbrink, Thomas Kleemann, Lars Eckardt, Johannes Brachmann, Bernd-Dieter Gonska, Stefan Kääb, Christian A. Perings, Werner Jung, Patrick Lugenbiel, Matthias Hochadel, Jochen Senges, Norbert Frey, Constanze Schmidt
Publikováno v:
Heart Rhythm. 20:501-509
Because of its antiarrhythmic potency and due to the lack of alternatives, amiodarone is often used for antiarrhythmic therapy in patients with ICD or CRT-D systems. To date, robust data on the safety and clinical benefit of amiodarone therapy in the
Autor:
Thomas Kleemann
Publikováno v:
Herz. 48:72-86
Autor:
Uwe Zeymer, Steffen Schneider, Matthias Hochadel, Thomas Kleemann, Martin Borggrefe, Ibrahim Akin, Hugo Katus, Dierk Thomas, Karl Werdan, Jochen Senges
Publikováno v:
Deutsches Ärzteblatt international.
Publikováno v:
Herzschrittmachertherapie + Elektrophysiologie. 32:383-388
Wir berichten uber eine 67-jahrige Patientin mit rezidivierenden Synkopen bei Asystolie und polymorphen Kammertachykardien ohne relevante strukturelle Herzerkrankung. Nach sekundarprophylaktischer ICD-Implantation, Betablocker- und Flecainidtherapie
Autor:
Thomas Kleemann, ReduceIT Investigators, A. Elsässer, C. Veltmann, Mathias Busch, Frank Birkenhauer, J. C. Geller, Armin Wöhrle, Peter Bramlage
Publikováno v:
Journal of Interventional Cardiac Electrophysiology. 61:339-348
Inappropriate implantable cardioverter-defibrillator (ICD) shocks are associated with greater healthcare resource utilization, poorer quality-of-life, and higher mortality. We aimed to investigate the performance of enhanced supraventricular tachycar
Autor:
Thomas Kleemann
Publikováno v:
Notaufnahme up2date. 2:143-156
Autor:
Stefan G. Spitzer, Johannes Brachmann, Harilaos Bogossian, Jochen Senges, Matthias Hochadel, Bernd-Dieter Gonska, Thomas Kleemann, Bernd Lemke, Christoph Stellbrink, Gerrit Frommeyer, Lars Eckardt, Sebastian K. G. Maier, Stefan Kääb, Hüseyin Ince
Publikováno v:
Clinical Research in Cardiology. 109:911-917
In patients with high risk for sudden cardiac death the implantation of a defibrillator is an established treatment. However the benefits and risks for patients in accordance to the number of the leads are not clear. Even in the current guidelines a